Our Partners











HCV treatment support for 1986-1990 claimants


Accessing treatments for hepatitis C through the Hepatitis C January 1, 1986 — July 1, 1990 Class Actions Settlement: What you need to know

If you are a patient who received tainted blood or blood products and a registered claimant of the Hepatitis C (HCV) 1986-1990 Class Actions Settlement (www.hepc8690.ca), now is a good time to speak to your doctor about new treatments for HCV. Treatment has progressed significantly, and now may be the right time for you to seek a cure.

Recently, new HCV therapies have been approved by Health Canada that shorten the duration of treatment, achieve a cure rate of more than 90%, minimize side effects compared to past treatments, and are interferon free. To complement your commitment to treatment, there are new resources in Canada that can help you start your journey.

Many companies that make and sell hepatitis C medications have programs to support patients throughout treatment.These programs offer assistance by providing drugs upfront to the 86-90 claimants through their specialty pharmacy. Once the 86-90 plan issues the reimbursement cheques to the patients for their treatment, they, in turn, must reimburse the pharmacy directly.

Typically, these programs are designed to provide a wide range of customized services including reimbursement assistance, education and ongoing disease management support. They will not only support health care professionals but people living with hepatitis C throughout their treatment journey to achieve a possible cure. This assistance will cover the entire treatment regimen that your doctor will prescribe including drugs from one or more pharmaceutical companies.

To enrol in one of these programs, speak to your doctor or your nurse or contact the programs directly for more information:


Program

Product

Phone #

AbbVie Care

Holkira™ Pak (paritaprevir/ritonavir/ ombitasvir tablets; dasabuvir tablets)

Technivie™
(ombitasvir/paritaprevir/ritonavir tablets)

1-844-471-2273

CLAIRE Patient Support Program

Daklinza™ (daclatasvir)

1-844-428-2559

Galexos™: BioAdvance® Patient Support Program

Galexos™ (simeprevir)

1-855-512-3740

Gilead Momentum HCV Support Program

Sovaldi®  (sofosbuvir)

Harvoni™ (ledipasvir and sofosbuvir tablet)

1-855-447-7977

Merck Care Hepatitis C Program

Zepatier™ (elbasvir and grazoprevir)

1-866-872-5773



Whether or not you are a claimant, the CHS advises you to speak to your specialist about the current evolution in hepatitis C therapy.

To learn more, your may download our brochure here or contact the CHS to order a copy.